Neurologic worsening during the acute phase of ischemic stroke
- PMID: 15767504
- DOI: 10.1001/archneur.62.3.393
Neurologic worsening during the acute phase of ischemic stroke
Abstract
Background: Although capacities for intensive monitoring of patients with stroke are still limited, patients at risk for early neurologic worsening are poorly defined.
Objective: To identify patients at risk for neurologic worsening.
Design: An inception cohort was assessed using the National Institutes of Health Stroke Scale (NIH-SS) at hospital admission and again 48 to 72 hours later.
Setting: Eleven neurologic departments with acute stroke units.
Patients: A total of 1964 consecutive patients admitted within 4 hours of the onset of acute cerebral ischemic symptoms.
Main outcome measures: Underlying reasons for and possible predictors of neurologic worsening.
Results: A total of 256 patients (13.0%) had an increased score of 1 point or more on the NIH-SS after 48 to 72 hours. Neurologic worsening was attributed to progressive stroke in 33.6% of patients, increased intracranial pressure in 27.3%, recurrent cerebral ischemia in 11.3%, and secondary parenchymal hemorrhage in 10.5%. A multivariate logistic regression analysis identified internal carotid artery occlusion, medial cerebral artery (M1) occlusion, territorial infarction, brainstem infarction, and diabetes mellitus as independent predictors of neurologic worsening on the NIH-SS. Worsening of key neurologic functions (consciousness, gaze, arm or leg motor function, and speech) occurred in 223 patients (11.4%), and worsening of 4 points or more on the NIH-SS total score occurred in 148 patients (7.5%).
Conclusion: Besides initial stroke severity and comorbid conditions, ultrasound and imaging can provide valuable information about the risk of worsening of stroke symptoms in the acute phase and thus can identify patients who could benefit most from intensive monitoring.
Similar articles
-
Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry.Neurology. 2010 Jan 12;74(2):136-41. doi: 10.1212/WNL.0b013e3181c9188b. Neurology. 2010. PMID: 20065248
-
Study on frequency and predictors of dementia after ischemic stroke: the Chongqing stroke study.J Neurol. 2004 Apr;251(4):421-7. doi: 10.1007/s00415-004-0337-z. J Neurol. 2004. PMID: 15083286
-
Thrombolysis in patients with marked clinical fluctuations in neurologic status due to cerebral ischemia.Arch Neurol. 2008 Aug;65(8):1041-3. doi: 10.1001/archneur.65.8.1041. Arch Neurol. 2008. PMID: 18695054
-
Cerebral aspergillosis in a diabetic patient leading to cerebral artery occlusion and ischemic stroke: a case report and literature review.J Stroke Cerebrovasc Dis. 2015 Jan;24(1):e39-43. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.025. Epub 2014 Nov 8. J Stroke Cerebrovasc Dis. 2015. PMID: 25444026 Review.
-
The effect of age, sex and strains on the performance and outcome in animal models of stroke.Neurochem Int. 2019 Jul;127:2-11. doi: 10.1016/j.neuint.2018.10.005. Epub 2018 Oct 3. Neurochem Int. 2019. PMID: 30291954 Review.
Cited by
-
Neutrophil-to-Lymphocyte Ratio Predicts Early Neurological Deterioration after Endovascular Treatment in Patients with Ischemic Stroke.Life (Basel). 2022 Sep 10;12(9):1415. doi: 10.3390/life12091415. Life (Basel). 2022. PMID: 36143451 Free PMC article.
-
The roles, mechanism, and mobilization strategy of endogenous neural stem cells in brain injury.Front Aging Neurosci. 2022 Aug 17;14:924262. doi: 10.3389/fnagi.2022.924262. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36062152 Free PMC article. Review.
-
Lipoic Acid Use and Functional Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke and Diabetes.PLoS One. 2016 Sep 27;11(9):e0163484. doi: 10.1371/journal.pone.0163484. eCollection 2016. PLoS One. 2016. PMID: 27677185 Free PMC article.
-
Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study.Exp Ther Med. 2022 Nov 22;25(1):22. doi: 10.3892/etm.2022.11721. eCollection 2023 Jan. Exp Ther Med. 2022. PMID: 36561618 Free PMC article.
-
Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes.Can J Physiol Pharmacol. 2010 Aug;88(8):788-95. doi: 10.1139/Y10-040. Can J Physiol Pharmacol. 2010. PMID: 20725136 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical